Abingworth
Abingworth LLP is a prominent life sciences investment firm founded in 1973, focused on transforming scientific discoveries into innovative medicines and treatments. As part of the global investment firm Carlyle, Abingworth manages over $1.25 billion across various life sciences funds, including its 11th fund and the Clinical Co-Development Co-Investment Fund. The firm has a strong investment track record, having invested in over 185 life science companies, resulting in more than 75 IPOs and over 50 mergers and acquisitions. Abingworth specializes in investment management and strategic collab
Investing activity
Abingworth is listed on AI Lounge as a venture capital investor based in London, England, United Kingdom. The deals desk records Series A and later AI rounds and seeds over $10M, so smaller checks may not show here yet.
Deals
Frequently asked questions about Abingworth
Where is Abingworth based?
Abingworth is based in London, England, United Kingdom.
How can founders reach Abingworth?
Founders on AI Lounge can see Abingworth's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Abingworth to their Investor Pipeline to track the conversation.